Testing effectiveness (Phase 2)Active Not RecruitingNCT05645692
What this trial is testing
A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer
Who this might be right for
Urothelial Cancer
Hoffmann-La Roche 204